Impactive Capital LP Meridian Bioscience Inc Transaction History

Impactive Capital LP

  • $2.69 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$30.9 - $33.55 $44.4 Million - $48.2 Million
-1,437,479 Reduced 33.26%
2,884,490 $90.9 Million
Q1 2022

May 16, 2022
BUY
$19.97 - $26.94 $80 Million - $108 Million
4,006,414 Added 1269.64%
4,321,969 $112 Million
Q4 2021

Feb 14, 2022
BUY
$17.46 - $21.61 $5.51 Million - $6.82 Million
315,555 New
315,555 $6.44 Million

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Impactive Capital LP Portfolio

Follow Impactive Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Impactive Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Impactive Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email